{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:14:43Z","timestamp":1794060883904,"version":"4.8.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020581","name":"AIRC Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ymthe.2026.07.050","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:21:31Z","timestamp":1785338491000},"page":"6028-6038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tissue-specific silencing of synthetic mRNAs by de-targeting elements maps vaccination-competent tissues and allows Cas9 de-immunization"],"prefix":"10.1016","volume":"34","author":[{"given":"Guendalina","family":"Froechlich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annagiulia","family":"Scognamiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Totaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Nocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Pellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Campanile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigia","family":"Infante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Miano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Centore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Molfetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Napolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Morena","family":"D\u2019Alise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6454-2824","authenticated-orcid":false,"given":"Emanuele","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.07.050_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101430","article-title":"New viral vectors for infectious diseases and cancer","volume":"50","author":"Sasso","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ymthe.2026.07.050_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.07.050_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2026.102851","article-title":"Lipid self-assembling nanoparticles as a novel platform for mRNA-based vaccination","volume":"37","author":"De Chiara","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.07.050_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12010059","article-title":"Biodistribution of RNA Vaccines and of Their Products: Evidence from Human and Animal Studies","volume":"12","author":"Pateev","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymthe.2026.07.050_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2026.07.050_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41541-025-01124-x","article-title":"Ionizable lipid nanoparticles of mRNA vaccines elicit NF-kappaB and IRF responses through toll-like receptor 4","volume":"10","author":"Zelkoski","year":"2025","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2026.07.050_bib7","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202500622R","article-title":"Lipid Nanoparticle: Beyond Delivery Vehicle-Unveiling Its Immunological Adjuvant Potential","volume":"39","author":"Amor","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2026.07.050_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.omtm.2018.06.006","article-title":"Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population","volume":"10","author":"Simhadri","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.050_bib9","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ymthe.2020.04.017","article-title":"AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9","volume":"28","author":"Li","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.050_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41467-024-55522-1","article-title":"Rational engineering of minimally immunogenic nucleases for gene therapy","volume":"16","author":"Raghavan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.050_bib11","doi-asserted-by":"crossref","first-page":"25634","DOI":"10.1073\/pnas.2002277117","article-title":"A mouse tissue atlas of small noncoding RNA","volume":"117","author":"Isakova","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.07.050_bib12","doi-asserted-by":"crossref","first-page":"23586","DOI":"10.1074\/jbc.M113.489302","article-title":"Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis","volume":"288","author":"Li","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.07.050_bib13","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1073\/pnas.0702409104","article-title":"miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely","volume":"104","author":"Zhou","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.07.050_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adl1698","article-title":"MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis","volume":"17","author":"De Rosa","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.050_bib15","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/cr.2013.145","article-title":"miR-142-3p regulates the formation and differentiation of hematopoietic stem cells in vertebrates","volume":"23","author":"Lu","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2026.07.050_bib16","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.3892\/mmr.2015.4456","article-title":"Dynamic expression of miR-206-3p during mouse skin development is independent of keratinocyte differentiation","volume":"12","author":"Mu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ymthe.2026.07.050_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/nu12020297","article-title":"Expression Patterns of Muscle-Specific miR-133b and miR-206 Correlate with Nutritional Status and Sarcopenia","volume":"12","author":"Iannone","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ymthe.2026.07.050_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/mt.2014.177","article-title":"Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV","volume":"23","author":"Mazzacurati","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.050_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.142230","article-title":"Peptide nucleic acid-mediated circularization of target RNA as tool to inhibit translation","volume":"308","author":"De Chiara","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ymthe.2026.07.050_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113407","article-title":"Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Herpes Simplex Oncolytic Virus","volume":"12","author":"Froechlich","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2026.07.050_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46830-5","article-title":"The common H232 STING allele shows impaired activities in DNA sensing, susceptibility to viral infection, and in monocyte cell function, while the HAQ variant possesses wild-type properties","volume":"13","author":"Froechlich","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.07.050_bib22","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1038\/s41598-020-61275-w","article-title":"Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysis","volume":"10","author":"Sasso","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.07.050_bib23","article-title":"Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer","volume":"14","author":"D'Alise","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.07.050_bib24","article-title":"Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors","volume":"32","author":"Troise","year":"2024","journal-title":"Mol. Ther. Oncol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:34:30Z","timestamp":1793374470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626006714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1525001626006714"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.050","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue-specific silencing of synthetic mRNAs by de-targeting elements maps vaccination-competent tissues and allows Cas9 de-immunization","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}